研究業績システム - 橋本剛 | 東京医科大学

（最終更新日 : null）

ハシモト　タケシ takeshi hashimoto
橋本剛

所属東京医科大学八王子医療センター外科関連分野(八王子) 泌尿器科(外関・八王子)

職種准教授

学術雑誌
研究論文（学術雑誌）	Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study 2025/08/19
研究論文（学術雑誌）	Rash and Endocrine Disorders Predict Improved Survival in Metastatic Renal Cell Carcinoma Treated With Immunotherapy 2025/08
研究論文（学術雑誌）	Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium 2025/01
記事・総説・解説・論説等（学術雑誌）	First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safety. 2024/11/01
記事・総説・解説・論説等（学術雑誌）	Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapy. 2024/10/07
全件表示（15件）

学会発表
2025/04/19	AEs of endocrine disorder and rash caused by ipilimumab and nivolumab for the treatment of mRCC improved overall survival （口頭発表，一般）
2025/04/18	Association of Body Mass Index and Tumor Response in Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: Data from the ULTRA-Japan Consortium （口頭発表，一般）
2025/04/18	Clinical outcomes of enfortumab vedotin in patients aged 80 years and older （口頭発表，一般）
2025/04/18	Oncological outcomes of upfront androgen receptor signaling inhibitors and combined androgen blockade with metastatic castration-sensitive prostate cancer （口頭発表，一般）
2025/04/17	Deciphering RCC Immunotherapy Outcomes: Insights from a Japanese Multi-Institutional Study on the CANLPH Score's Impact （口頭発表，一般）
全件表示（29件）